Search

everythinglearnresearchcommunity

for

Search:↓

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Fibroblast and immune cell interactions affect tissue repair and fibrosis.

Spironolactone may help improve symptoms and tear quality in dry eye disease.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

CD44 variant changes start alopecia areata, but don't maintain it.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

A woman's hair loss led to discovering she had lupus.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

A 36-year-old woman with low potassium levels was found to have Cushing disease, and after treatment, her potassium levels normalized.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Vitamin D is crucial for skin health and managing skin diseases.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.